KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other financing activities: 2010-2024

Historic Other financing activities for Emergent BioSolutions (EBS) over the last 6 years, with Sep 2024 value amounting to $8.7 million.

  • Emergent BioSolutions' Other financing activities was N/A to $8.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $28.1 million, marking a year-over-year change of. This contributed to the annual value of $14.6 million for FY2024, which is N/A change from last year.
  • Per Emergent BioSolutions' latest filing, its Other financing activities stood at $8.7 million for Q3 2024, which was down 35.07% from $13.4 million recorded in Q4 2018.
  • In the past 5 years, Emergent BioSolutions' Other financing activities registered a high of $8.7 million during Q3 2024, and its lowest value of $8.7 million during Q3 2024.
  • In the last 1 years, Emergent BioSolutions' Other financing activities had a median value of $8.7 million in 2024 and averaged $8.7 million.